Ecnoglutide vs Liraglutide

Ecnoglutide is an experimental GLP-1 drug still in development, while Liraglutide is an FDA-approved GLP-1 treatment sold under the brand names Saxenda and Victoza. Liraglutide is approved to treat type 2 diabetes, obesity, and to reduce cardiovascular risk, whereas Ecnoglutide has no approved uses yet. Both work the same way by mimicking a gut hormone, but Ecnoglutide is not yet available for patients.

AI summary of the sources below.